ZA935647B - Treatment of sickle cell disease - Google Patents

Treatment of sickle cell disease

Info

Publication number
ZA935647B
ZA935647B ZA935647A ZA935647A ZA935647B ZA 935647 B ZA935647 B ZA 935647B ZA 935647 A ZA935647 A ZA 935647A ZA 935647 A ZA935647 A ZA 935647A ZA 935647 B ZA935647 B ZA 935647B
Authority
ZA
South Africa
Prior art keywords
treatment
sickle cell
cell disease
disease
sickle
Prior art date
Application number
ZA935647A
Inventor
Catherine Anne Rice-Evans
Original Assignee
British Tech Group
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by British Tech Group filed Critical British Tech Group
Publication of ZA935647B publication Critical patent/ZA935647B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ZA935647A 1992-08-04 1993-08-04 Treatment of sickle cell disease ZA935647B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB929216506A GB9216506D0 (en) 1992-08-04 1992-08-04 Improvements in or relating to the treatment of sickle cell disease

Publications (1)

Publication Number Publication Date
ZA935647B true ZA935647B (en) 1995-02-06

Family

ID=10719768

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA935647A ZA935647B (en) 1992-08-04 1993-08-04 Treatment of sickle cell disease

Country Status (4)

Country Link
AU (1) AU4719793A (en)
GB (2) GB9216506D0 (en)
WO (1) WO1994003169A1 (en)
ZA (1) ZA935647B (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2244967T3 (en) * 1995-09-29 2005-12-16 Novartis Ag NEW HYDROXIPIRIDINONES.
US6087398A (en) * 1996-03-01 2000-07-11 South Alabama Medical Science Foundation Sickle cell anemia treatment
IT1312086B1 (en) * 1999-04-21 2002-04-04 Zambon Spa USE OF NAC FOR THE PREPARATION OF A DRUG SUITABLE FOR INTRAVENOUS ADMINISTRATION FOR STRESS PREVENTION
DE10160796A1 (en) * 2001-12-11 2003-06-26 Wulf Droege Use of cysteine or its derivative for increasing tissue oxygen supply, respiratory activity and/or plasma erythropoietin levels, e.g. in cancer or cardio-pulmonary disease patients
WO2010045220A1 (en) 2008-10-14 2010-04-22 Edison Pharmaceuticals, Inc. Treatment of oxidative stress disorders including contrast nephropathy, radiation damage and disruptions in the function of red cells
CN102190644B (en) * 2011-03-31 2012-11-21 浙江大学 Chiral 3-hydroxypyridin-4-one derivatives, synthesis and application thereof
EP3960168A1 (en) * 2020-08-28 2022-03-02 Université de Genève Compositions and methods comprising d-cysteine or a derivative thereof

Also Published As

Publication number Publication date
AU4719793A (en) 1994-03-03
GB9216506D0 (en) 1992-09-16
GB2269748A (en) 1994-02-23
WO1994003169A1 (en) 1994-02-17
GB9316004D0 (en) 1993-09-15

Similar Documents

Publication Publication Date Title
AP9000206A0 (en) Treatment of conditions & diseases
GB8606913D0 (en) Treatment of sickle cell disease
AP9200358A0 (en) Orthomolecular method of treating sickle cell disease
ZA935647B (en) Treatment of sickle cell disease
GB9222260D0 (en) Skin treatment
GB9201920D0 (en) Novel treatment i
ZA914435B (en) Treatment of disease
IL104755A0 (en) Treatment of glaucoma
IL107768A0 (en) Treatment of agricultural produce
GB9217124D0 (en) Medical treatment
GB9220194D0 (en) Medical electrode
ZA9189B (en) Treatment of protozoal diseases
GB9216360D0 (en) Treatment of blood
GB8707427D0 (en) Treatment of dandruff
AU7695891A (en) Treatment of autoimmune diseases
GB9218773D0 (en) Skin treatment
ZA936136B (en) Treatment of skin diseases
GB9210477D0 (en) Treatment of hay
GB2266241B (en) Treatment of pastures
GB8829366D0 (en) Treatment of disease
GB9222195D0 (en) Medical treatment
GB9204062D0 (en) Medical treatment
GB9206289D0 (en) Medical treatment pack
GB8827028D0 (en) Crop treatment
GB9207595D0 (en) Treatment of pastures